HMG
Human Menopausal Gonadotropin / Menopur / Pergonal
Human Menopausal Gonadotropin (HMG) is a urinary-derived preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in approximately equal proportions, extracted and purified from the urine of postmenopausal women. It is FDA-approved for the treatment of infertility in both men and women, stimulating follicular development in women and spermatogenesis in men. Brand names include Menopur and Pergonal, and it remains a cornerstone of assisted reproductive technology.
Mécanisme d'action
Combination of FSH and LH extracted from post-menopausal urine. Directly stimulates ovarian follicular development (FSH component) and supports ovulation and corpus luteum function (LH component). Used in assisted reproduction protocols.
Protocoles de recherche
Pour des fins de recherche uniquement. Pas de conseil médical.
Fertility protocols use 75-150 IU daily via intramuscular injection, adjusted based on ovarian response monitoring. Male protocols for spermatogenesis use 75-150 IU 2-3 times weekly with HCG.
Notes de recherche
Clinical Research Status
HMG has been used in fertility medicine since the 1960s and holds FDA approval for ovulation induction in women with anovulatory infertility and for spermatogenesis stimulation in men with hypogonadotropic hypogonadism. Highly purified urinary HMG (Menopur) and recombinant alternatives (Gonal-F for FSH, Luveris for LH) provide different formulation options. Ongoing research compares urinary-derived versus recombinant gonadotropins for IVF outcomes.
Key Published Findings
Clinical trials demonstrate that HMG protocols produce equivalent or slightly superior IVF outcomes compared to recombinant FSH alone, possibly due to the LH component's contribution to follicular steroidogenesis. In male infertility, HMG combined with HCG can restore spermatogenesis in men with gonadotropin deficiency, with sperm appearing in ejaculate typically within 6-18 months. The LH activity in HMG supports theca cell androgen production necessary for optimal follicular development.
Safety Profile
Ovarian hyperstimulation syndrome (OHSS) is the most significant risk, ranging from mild (abdominal bloating) to severe (ascites, thromboembolism), requiring careful ultrasound and estradiol monitoring during stimulation cycles. Multiple pregnancy rates are elevated (15-25% in IUI cycles) due to multi-follicular development. In male patients, adverse effects are generally limited to gynecomastia and acne from increased testosterone and estrogen production.
Comparison to Related Compounds
Unlike recombinant FSH (follitropin alfa/beta), HMG contains both FSH and LH activity, providing a more complete gonadotropin stimulus. Compared to HCG which mimics only LH, HMG provides direct FSH stimulation critical for Sertoli cell function and spermatogenesis initiation. Highly purified HMG (Menopur) contains LH activity primarily from HCG co-purified from urine rather than true LH, though biological activity is equivalent.
Community Observations
Fertility specialists often debate the clinical significance of the LH component in HMG versus pure FSH protocols, with some evidence favoring HMG in specific patient populations (older women, poor responders). In male fertility protocols, HMG is typically added to HCG after initial testosterone normalization to specifically target spermatogenesis. Cost considerations remain relevant as urinary-derived preparations are generally less expensive than recombinant alternatives.
Moitié de vie
~24-48 hours
Réconstitution
Sterile diluent provided with kit
Conservation
Lyophilisé
Refrigerate 2-8C.
Réconstitué
Use immediately after reconstitution.
Statut légal aux États-Unis
Autres noms connus
Questions fréquentes
Qu'est-ce que HMG ?
Human Menopausal Gonadotropin (HMG) is a urinary-derived preparation containing both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in approximately equal proportions, extracted and purified from the urine of postmenopausal women. It is FDA-approved for the treatment of infertility in both men and women, stimulating follicular development in women and spermatogenesis in men. Brand names include Menopur and Pergonal, and it remains a cornerstone of assisted reproductive technology.
Comment agit HMG ?
Combination of FSH and LH extracted from post-menopausal urine. Directly stimulates ovarian follicular development (FSH component) and supports ovulation and corpus luteum function (LH component). Used in assisted reproduction protocols.
Quel est le statut réglementaire de HMG aux États-Unis ?
FDA-approved (Rx only)
Quelle est la demi-vie de HMG ?
~24-48 hours
Sous quels autres noms HMG est-il connu ?
Human Menopausal Gonadotropin, Menopur, Pergonal
Peptide Contacts fournit des résumés basés sur la recherche à des fins d’information uniquement. Nous ne hébergeons, n’épandons ni ne recommandons les documents des fournisseurs. Toutes les certificats d'analyse, certificats GMP et communications du fournisseur doivent être demandés et vérifiés directement par l'acheteur. Rien sur cette plateforme ne constitue un avis juridique, médical ou professionnel. Les utilisateurs sont entièrement responsables de la vérification des informations du fournisseur et de l’assurance de la conformité avec toutes les lois locales, d'état et fédérales applicables avant l'achat de tout produit chimique de recherche. L'utilisation de cette plateforme constitue l'acceptation pleine et entière de la responsabilité personnelle.
Lire la déclaration complète